Oxoid, a world leading microbiology brand, has today announced that the first prize of £5,000 in the 2008/2009 Oxoid Infection Control Team of the Year Awards, has been awarded to the Heart of England NHS Foundation Trust, Birmingham, England. The Awards entry demonstrated sustained commitment to reducing healthcare associated infections.

As concerns are raised about the limited use of more expensive treatments for osteoporosis, Roche's comprehensive range of Elecsys ® bone marker assays provides valuable information for the diagnostic and prognostic assessment of bone metabolism in patients with, or at risk of, osteoporosis and other bone diseases, in addition to providing an early indication of response and adherence to treatment.